Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05788666 · ClinicalTrials.gov registry record · NA
Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease
A NA study of Ischemic Heart Disease, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05788666 is a NA study of Ischemic Heart Disease that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 150 participants, below the 256-participant average among 14 other Ischemic Heart Disease trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05788666, a NA study of Ischemic Heart Disease, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to expand the use of the NYU GeriKit mobile application ("app") in a diverse range of settings to better phenotype older patients, which will enhance both research and patient care.
Conditions Studied
Interventions
- PROCEDURE GeriKit Mobile Application
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-01-18 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05788666
The ClinicalTrials.gov registry entry for NCT05788666 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 256-participant average among 14 other Ischemic Heart Disease trials with a reported enrollment target (41% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ischemic Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which GeriKit Mobile Application is the first listed.
NCT05788666 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05788666 about?
NCT05788666 is a clinical study titled "Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease". This study seeks to expand the use of the NYU GeriKit mobile application ("app") in a diverse range of settings to better phenotype older patients, which will enhance both research and patient care.
What is the current status of trial NCT05788666?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-01-18. Estimated completion is 2027-12-31.
What conditions does trial NCT05788666 study?
This clinical trial studies the following conditions: Ischemic Heart Disease.
What interventions are being tested in trial NCT05788666?
The interventions under investigation include: GeriKit Mobile Application (PROCEDURE).
Who is sponsoring clinical trial NCT05788666?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05788666 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia
RECRUITING · NA
-
A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction
ACTIVE NOT RECRUITING · NA
-
Chronic Total Occlusion Percutaneous Coronary Intervention Study
COMPLETED · NA
-
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
RECRUITING
-
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
RECRUITING
-
Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.